More reports from the UK on the use of BTM in non-burn wound reconstruction.
Two abstracts from the University Hospitals Coventry & Warwickshire have been published in the Annals of the Royal College of Surgeons of England, March 2024.
Both abstracts report on a retrospective observational study of 37 patients who underwent non-burn wound reconstruction using Novosorb BTM between January 2020 and September 2022.
Conclusions This study underscores Novosorb as a valuable addition to non-burn wound management, even in challenging clinical scenarios. Vigilant clinical monitoring and meticulous wound bed optimisation are essential, especially for elderly, diabetic, or co-morbid patients with chronic or malignant wounds. Despite potential complications, Novosorb consistently proves to be a robust and reliable choice for enhancing patient outcomes in non-burn wound reconstruction.
- Wound aetiologies included: acute trauma (51.4%), chronic wounds (24.3%), infections with tissue loss (16.2%), and soft tissue or skin cancer (8.1%).TBSA was 1%, most frequent wound site was lower limb (56.8%), whereas wound bed was muscle/fascia (48.6%).
- There was a 74.3% success rate in achieving Novosorb integration.
- Notably, all patients achieved complete wound healing. Median time to complete wound healing was 101 days.
- Patients aged 65 and above experienced higher complication rates (72.7%), while younger patients exhibited significantly lower complication rates (34.6%).
- Complications occurred in 45.9% of patients: highest rates seen in cases involving malignancy (66.7%) and chronic wounds (55.6%).
- Factors such as wound bed characteristics, and diabetic status showed no substantial influence on either integration or complication rates.
- Age, gender and smoking history were not significantly associated with BTM loss.
- Forums
- ASX - By Stock
- PNV
- The Clinicians Speak
The Clinicians Speak, page-844
- There are more pages in this discussion • 133 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add PNV (ASX) to my watchlist
(20min delay)
|
|||||
Last
$2.31 |
Change
0.060(2.67%) |
Mkt cap ! $1.594B |
Open | High | Low | Value | Volume |
$2.28 | $2.32 | $2.27 | $4.077M | 1.776M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 136 | $2.30 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$2.31 | 10498 | 3 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 136 | 2.300 |
4 | 21305 | 2.290 |
2 | 12526 | 2.280 |
2 | 5514 | 2.270 |
3 | 5527 | 2.260 |
Price($) | Vol. | No. |
---|---|---|
2.310 | 10498 | 3 |
2.320 | 73956 | 9 |
2.330 | 18415 | 5 |
2.340 | 11081 | 3 |
2.350 | 64050 | 12 |
Last trade - 16.10pm 03/06/2024 (20 minute delay) ? |
|
|||||
Last
$2.30 |
  |
Change
0.060 ( 2.40 %) |
|||
Open | High | Low | Volume | ||
$2.27 | $2.32 | $2.27 | 483437 | ||
Last updated 15.59pm 03/06/2024 ? |
Featured News
PNV (ASX) Chart |